Instrument Inactif

Communiqués Liminal BioSciences Inc.

Actions

PJ2

CA53272L2021

Recherche biotechnologique et médicale

Communiqués

26/09/23	Liminal BioSciences : Notice	PU
12/09/23	Liminal BioSciences : Supplement to the Arrangement Circular – Special Meeting September 2023	PU
17/08/23	Liminal BioSciences : Notice of Special Meeting of Shareholders and Management Information Circular dated August 16, 2023 - Form 6-K	PU
17/08/23	Liminal BioSciences : Form of Proxy – Special Meeting September 2023	PU
17/08/23	Liminal BioSciences : Other	PU
16/08/23	Liminal BioSciences : Letter of Transmittal – Special Meeting September 2023	PU
16/08/23	Liminal BioSciences : Notice of Special Meeting - Special Meeting September 2023	PU
16/08/23	Liminal BioSciences : Arrangement Circular – Special Meeting September 2023	PU
16/08/23	LIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED ARRANGEMENT WITH STRUCTURED ALPHA LP	AQ
16/08/23	Liminal BioSciences : Other	PU
16/08/23	Liminal BioSciences : Form of proxy - English	PU
08/08/23	Liminal BioSciences : 52-109F2 - Certification of interim filings - CEO (E)	PU
08/08/23	Liminal BioSciences : 52-109F2 - Certification of interim filings - CFO (E)	PU
08/08/23	Liminal BioSciences : Annual MD&A - English	PU
08/08/23	Liminal BioSciences : Interim financial statements/report - English	PU
08/08/23	Liminal BioSciences : News release - English	PU
02/08/23	Liminal BioSciences : Notice of the meeting and record date - English	PU
02/08/23	Liminal BioSciences : Notice of the meeting and record date - French	PU
05/06/23	Liminal BioSciences Provides R&D Update	AQ
05/04/23	THOMVEST SUBMITS PROPOSAL TO ACQUIRE LIMINAL BIOSCIENCES ON AN ALL CASH BASIS	AQ
20/01/23	Liminal BioSciences : VIA SEDAR - Form 6-K	PU
15/12/22	Liminal BioSciences : Notice of Special Meeting of Shareholders and Management Information Circular December 12, 2022 - Form 6-K	PU
28/11/22	Liminal BioSciences Announces Holding of Special Meeting of Shareholders	AQ
09/11/22	Liminal BioSciences to Report Third Quarter 2022 Financial Results on November, 2022	AQ
10/08/22	Liminal BioSciences : Reports Second Quarter 2022 Financial Results and Business Highlights - Form 6-K	PU